본문 바로가기
KERD
논문KCI 등재

Effects of endodontic treatment on salivary levels of CGRP and substance P: a pilot study

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류치의학

초록

Objectives: The aim of this study was to evaluate the effects of endodontic treatment on levels of substance P (SP) and calcitonin gene-related peptide (CGRP) in the saliva of patients with symptomatic apical periodontitis. Materials and Methods: Twelve patients with mandibular molars with symptomatic apical periodontitis were enrolled in this study. An initial saliva sample was collected just before administration of anesthesia for root canal treatment, which was performed at the first visit. A second saliva sample was collected at a control visit 1 week after treatment. Salivary SP and CGRP levels were evaluated quantitatively using biochemical assays. The data were analyzed using Pearson correlation analysis, the paired samples t-test, and the Mann-Whitney U test (p = 0.05). Results: The postoperative salivary level of SP was significantly lower than the preoperative level (p = 0.005). However, the postoperative salivary level of CGRP was similar to the preoperative level (p = 0.932). Visual analog scale (VAS) scores of patients' subjective pain were found to be positively correlated with salivary levels of SP (r = 0.421; p = 0.040). No statistically significant correlations were observed between salivary levels of CGRP and VAS scores for patients' subjective percussion tenderness (p = 0.533) or VAS scores for patients' subjective pain (p = 0.459). Conclusions: According to the results of the present study, salivary SP levels may be used as an objective indicator in the diagnosis and assessment of the degree of pain in endodontic diseases.

Abstract

Objectives: The aim of this study was to evaluate the effects of endodontic treatment on levels of substance P (SP) and calcitonin gene-related peptide (CGRP) in the saliva of patients with symptomatic apical periodontitis. Materials and Methods: Twelve patients with mandibular molars with symptomatic apical periodontitis were enrolled in this study. An initial saliva sample was collected just before administration of anesthesia for root canal treatment, which was performed at the first visit. A second saliva sample was collected at a control visit 1 week after treatment. Salivary SP and CGRP levels were evaluated quantitatively using biochemical assays. The data were analyzed using Pearson correlation analysis, the paired samples t-test, and the Mann-Whitney U test (p = 0.05). Results: The postoperative salivary level of SP was significantly lower than the preoperative level (p = 0.005). However, the postoperative salivary level of CGRP was similar to the preoperative level (p = 0.932). Visual analog scale (VAS) scores of patients' subjective pain were found to be positively correlated with salivary levels of SP (r = 0.421; p = 0.040). No statistically significant correlations were observed between salivary levels of CGRP and VAS scores for patients' subjective percussion tenderness (p = 0.533) or VAS scores for patients' subjective pain (p = 0.459). Conclusions: According to the results of the present study, salivary SP levels may be used as an objective indicator in the diagnosis and assessment of the degree of pain in endodontic diseases.

참고문헌 (41)

  1. Stashenko P, "Periapical inflammatory responses and their modulation", Crit Rev Oral Biol Med, 9, pp.498~521 (1998)
  2. Caviedes-Bucheli J, "Neuropeptides in dental pulp : the silent protagonists", J Endod, 34, pp.773~788 (2008)
  3. Siqueira JF Jr, "Incidence of postoperative pain after intracanal procedures based on an antimicrobial strategy", J Endod, 28, pp.457~460 (2002)
  4. Steinhoff M, "Modern aspects of cutaneous neurogenic inflammation", Arch Dermatol, 139, pp.1479~1488 (2003)
  5. Caviedes-Bucheli J, "The effect of different vasoconstrictors and local anesthetic solutions on substance P expression in human dental pulp", J Endod, 35, pp.631~633 (2009)
  6. Roosterman D, "Neuronal control of skin function : the skin as a neuroimmunoendocrine organ", Physiol Rev, 86, pp.1309~1379 (2006)
  7. Peters EM, "Neuropeptide control mechanisms in cutaneous biology : physiological and clinical significance", J Invest Dermatol, 126, pp.1937~1947 (2006)
  8. N'Diaye A, "Substance P and calcitonin gene-related peptide: key regulators of cutaneous microbiota homeostasis", Front Endocrinol (Lausanne), 8, pp.15~ (2017)
  9. Fischer HP, "A possible role for saliva as a diagnostic fluid in patients with chronic pain", Semin Arthritis Rheum, 27, pp.348~359 (1998)
  10. Lee YH, "Saliva : an emerging biofluid for early detection of diseases", Am J Dent, 22, pp.241~248 (2009)
  11. Li Y, "The Oral Fluid MEMS", NEMS Chip(OFMNC) : diagnostic and translational applications, 2005, pp.18, 3~5
  12. Nicolodi M, "Sensory neuropeptides (substance P, calcitonin gene-related peptide) and vasoactive intestinal polypeptide in human saliva: their pattern in migraine and cluster headache", Cephalalgia, 10, pp.39~50 (1990)
  13. Borelli V, "Neuropeptides in saliva of subjects with burning mouth syndrome : a pilot study", Oral Dis, 16, pp.365~374 (2010)
  14. Zidverc-Trajkovic J, "Calcitonin gene-related peptide levels in saliva of patients with burning mouth syndrome", J Oral Pathol Med, 38, pp.29~33 (2009)
  15. Haririan H, "Salivary neuropeptides, stress, and periodontitis", J Periodontol, 89, pp.9~18 (2018)
  16. Cao YQ, "Primary afferent tachykinins are required to experience moderate to intense pain", Nature, 392, pp.390~394 (1998)
  17. Sabbadini E, "The submandibular gland: a key organ in the neuro-immuno-regulatory network?", Neuroimmunomodulation, 2, pp.184~202 (1995)
  18. Lembeck F, "Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation", Naunyn Schmiedebergs Arch Pharmacol, 310, pp.175~183 (1979)
  19. Mashaghi A, "Neuropeptide substance P and the immune response", Cell Mol Life Sci, 73, pp.4249~4264 (2016)
  20. De Felipe C, "Altered nociception, analgesia and aggression in mice lacking the receptor for substance P", Nature, 392, pp.394~397 (1998)
  21. Bessac BF, "Breathtaking TRP channels: TRPA1 and TRPV1 in airway chemosensation and reflex control", Physiology(Bethesda), 23, pp.360~370 (2008)
  22. Gunthorpe MJ, "The diversity in the vanilloid(TRPV)receptor family of ion channels", Trends Pharmacol Sci, 23, pp.183~191 (2002)
  23. Ekström J, "Vasoactive intestinal peptide and substance P in salivary glands of the rat following denervation or duct ligation", Regul Pept, 10, pp.1~10 (1984)
  24. de Paula F, "Overview of human salivary glands: highlights of morphology and developing processes", Anat Rec(Hoboken), 300, pp.1180~1188 (2017)
  25. Konttinen YT, "Peptide-containing nerves in labial salivary glands in Sjögren's syndrome", Arthritis Rheum, 35, pp.815~820 (1992)
  26. Awawdeh LA, "Quantitative analysis of substance P, neurokinin A and calcitonin gene-related peptide in gingival crevicular fluid associated with painful human teeth", Eur J Oral Sci, 110, pp.185~191 (2002)
  27. Taylor JJ, "Gingival crevicular fluid and saliva", Periodontol 2000, 70, pp.7~10 (2016)
  28. Schlereth T, "Interaction of calcitonin gene related peptide(CGRP)and substance P(SP)in human skin", Neuropeptides, 59, pp.57~62 (2016)
  29. Albo F, "Neuropeptide enzyme hydrolysis in allergic human saliva", Peptides, 23, pp.185~192 (2002)
  30. Lundy FT, "Carboxypeptidase-mediated metabolism of calcitonin gene-related peptide in human gingival crevicular fluid--a rôle in periodontal inflammation?", J Clin Periodontol, 27, pp.499~505 (2000)
  31. Ahmad M, "Substance P concentration in saliva of patients who report dental pain", J Adv Oral Res, 5, pp.1~5 (2014)
  32. Caviedes-Bucheli J, "Quantification of neuropeptides (calcitonin gene-related peptide, substance P, neurokinin A, neuropeptide Y and vasoactive intestinal polypeptide) expressed in healthy and inflamed human dental pulp", Int Endod J, 39, pp.394~400 (2006)
  33. Marco B, "The effect of aging on nerve morphology and substance P expression in mouse and human corneas", Invest Ophthalmol Vis Sci, 59, pp.5329~5335 (2018)
  34. Luthman J, "Immunohistochemical study of neurochemical markers in gingiva obtained from periodontitis-affected sites", J Periodontal Res, 24, pp.267~278 (1989)
  35. Bartold PM, "Substance P: an immunohistochemical and biochemical study in human gingival tissues. A role for neurogenic inflammation?", J Periodontol, 65, pp.1113~1121 (1994)
  36. Bender IB, "Pulpal pain diagnosis--a review", J Endod, 26, pp.175~179 (2000)
  37. Dawidson I, "Neuropeptides in the saliva of healthy subjects", Life Sci, 60, pp.269~278 (1997)
  38. Tschoppe P, "Etiologic factors of hyposalivation and consequences for oral health", Quintessence Int, 41, pp.321~333 (2010)
  39. Alobaid AS, "Radiographic and clinical outcomes of the treatment of immature permanent teeth by revascularization or apexification : a pilot retrospective cohort study", J Endod, 40, pp.1063~1070 (2014)
  40. Yazdanfar I, "Effects of diode laser on direct pulp capping treatment : a pilot study", Lasers Med Sci, 30, pp.1237~1243 (2015)
  41. Marukawa H, "Salivary substance P, 5-hydroxytryptamine, and gamma-aminobutyric acid levels in migraine and tension-type headache", Headache, 36, pp.100~104 (1996)

관련 논문AI추천

이 간행물의 다른 논문 (15건)